MFN a ‘seismic shift’ for pharma, says Novartis CEO
By Megan Brodie 9 months ago | In Companies, Politics, Reimbursement- 9 months ago
23 January 2026 Novartis global CEO Vas Narasimhan has sounded a warning bell for countries…
This is subscriber-only content. Please login to continue reading.